Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Clinical trial NCT05611645 · UNKNOWN
Trial details
- NCT number
- NCT05611645
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.